Methods to measure the intracellular concentration of unlabeled compounds within cultured cells using liquid chromatography/tandem mass spectrometry.

No abstract is available for this paper.

• Publication year

  2008

• Venue

  Analytical Biochemistry

• Publication date

  2008-12-15

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.ab.2008.08.012PMID 18790690
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Saturable Uptake of Lipophilic Amine Drugs into Isolated Hepatocytes: Mechanisms and Consequences for Quantitative Clearance Prediction

  2007cited by this paper
• Drug adsorption to plastic containers and retention of drugs in cultured cells under in vitro conditions.

  2006cited by this paper
• Regulation of the CYP1A1 Gene by 2,3,7,8-Tetrachlorodibenzo-p-dioxin but Not by β-Naphthoflavone or 3-Methylcholanthrene Is Altered in Hepatitis C Virus Replicon-Expressing Cells

  2006cited by this paper
• Intracellular and plasma pharmacokinetics of efavirenz in HIV-infected individuals.

  2005cited by this paper
• Dynamic imaging of protease activity with fluorescently quenched activity-based probes

  2005cited by this paper
• Selective Intracellular Activation of a Novel Prodrug of the Human Immunodeficiency Virus Reverse Transcriptase Inhibitor Tenofovir Leads to Preferential Distribution and Accumulation in Lymphatic Tissue

  2005cited by this paper
• Intracellular measurements of anti-HIV drugs indinavir, amprenavir, saquinavir, ritonavir, nelfinavir, lopinavir, atazanavir, efavirenz and nevirapine in peripheral blood mononuclear cells by liquid chromatography coupled to tandem mass spectrometry.

  2005cited by this paper
• Adaptive Mutations Producing Efficient Replication of Genotype 1a Hepatitis C Virus RNA in Normal Huh7 Cells

  2004cited by this paper
• P-glycoprotein and MRP1 expression and reduced ritonavir and saquinavir accumulation in HIV-infected individuals.

  2002cited by this paper
• Application of LC/MS/MS in the quantitation of SU101 and SU0020 uptake by 3T3/PDGFr cells.

  2002cited by this paper
• Intracellular Accumulation of Human Immunodeficiency Virus Protease Inhibitors

  2002cited by this paper
• Intracellular concentration of the HIV protease inhibitors indinavir and saquinavir in human endothelial cells.

  2001cited by this paper
• Differences in the intracellular accumulation of HIV protease inhibitors in vitro and the effect of active transport

  2001cited by this paper
• Efficient initiation of HCV RNA replication in cell culture.

  2000cited by this paper
• Cellular uptake of fluvastatin, an inhibitor of HMG-CoA reductase, by rat cultured hepatocytes and human aortic endothelial cells.

  1999cited by this paper
• Kinetics of Antiviral Activity and Intracellular Pharmacokinetics of Human Immunodeficiency Virus Type 1 Protease Inhibitors in Tissue Culture

  1999cited by this paper
• Human serum attenuates the activity of protease inhibitors toward wild-type and mutant human immunodeficiency virus.

  1998cited by this paper
• Cellular uptake profile of paclitaxel using liquid chromatography tandem mass spectrometry.

  1998cited by this paper
• Evaluation of cellular uptake, tumor retention, radiation response, and tumor pathophysiology in experimental solid tumors after an intratumoral infusion of colloidal 32P

  1997cited by this paper
• Human serum alpha 1 acid glycoprotein reduces uptake, intracellular concentration, and antiviral activity of A-80987, an inhibitor of the human immunodeficiency virus type 1 protease

  1996cited by this paper
• Modulation of P‐glycoprotein activity by estramustine is limited by binding to plasma proteins

  1995cited by this paper
• Temperature dependence studies of adriamycin uptake and cytotoxicity.

  1987cited by this paper
• Kinetics of uptake and intracellular binding of Cyclosporine A in RAJI cells, in vitro.

  1986cited by this paper

• Data-Driven Design of PROTAC Linkers to Improve PROTAC Cell Membrane Permeability.

  2026cites this paper
• A Streamlined High Performance Liquid Chromatography with Tandem Mass Spectrometry Based Workflow for Rapid Screening of Cellular Accumulation of Small Molecules

  2025cites this paper
• Mechanistic Characterization of the Potency of THIOMAB Antibody-Drug Conjugates Targeting Staphylococcus aureus and ETbR-Expressing Tumor Cells Using Quantitative LC-MS/MS Analysis of Intracellular Drug Accumulation.

  2025cites this paper
• Correlation between Membrane Permeability and the Intracellular Degradation Activity of Proteolysis-Targeting Chimeras.

  2024cites this paper
• CO prodrugs: a new scaffold of adamantane-fused norbornen-7-ones with tunable water solubility

  2024cites this paper
• Subtype-selective prenylated isoflavonoids disrupt regulatory drivers of MYCN-amplified cancers.

  2023cites this paper
• PD146176 affects human EA.hy926 endothelial cell function by differentially modulating oxylipin production of LOX, COX and CYP epoxygenase.

  2022cites this paper
• Design and Applications of Bifunctional Small Molecules in Biology.

  2020cites this paper
• Understanding and Improving the Membrane Permeability of VH032-Based PROTACs

  2020cites this paper
• Assessing the Cell Permeability of Bivalent Chemical Degraders Using the Chloroalkane Penetration Assay.

  2019cites this paper
• Reducing Mutant Huntingtin Protein Expression in Living Cells by a Newly Identified RNA CAG Binder.

  2018cites this paper
• Development and validation of a high‐performance liquid chromatography method for the quantitation of intracellular PARP inhibitor Olaparib in cancer cells

  2018cites this paper
• Optimisation du traitement du cancer du sein Triple-Négatif : développement des modèles de culture cellulaire en trois dimensions, efficacité de l'Olaparib (anti-PARP1) en combinaison avec la radiothérapie et chimiorésistance instaurée par les protéines Multi Drug Résistance

  2018cites this paper
• Emerging Methods and Design Principles for Cell-Penetrant Peptides.

  2018cites this paper
• Neue Methoden und Designprinzipien für zellgängige Peptide

  2018cites this paper
• Cell-Penetrating CaCO3 Nanocrystals for Improved Transport of NVP-BEZ235 across Membrane Barrier in T-Cell Lymphoma

  2018cites this paper
• A Versatile Method to Determine the Cellular Bioavailability of Small-Molecule Inhibitors

  2017cites this paper
• Multivalent Small-Molecule Pan-RAS Inhibitors.

  2017cites this paper
• Direct Measurement of Intracellular Compound Concentration by RapidFire Mass Spectrometry Offers Insights into Cell Permeability

  2016influential citation
• Rational design of selective small-molecule inhibitors for β-catenin/B-cell lymphoma 9 protein-protein interactions.

  2015cites this paper
• Intracellular drug concentration and disposition--the missing link?

  2014cites this paper
• Hepatitis C NS5B polymerase inhibitors: functional equivalents for the benzothiadiazine moiety.

  2011cites this paper
• Subtype-selective prenylated isoflavonoids disrupt regulatory drivers of MYCN-amplified cancers

  year unknowncites this paper